Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1:2021:20-0156.
doi: 10.1530/EDM-20-0156. Online ahead of print.

Status epilepticus and diabetes ketoacidosis: uncommon clinical presentations of acromegaly

Affiliations

Status epilepticus and diabetes ketoacidosis: uncommon clinical presentations of acromegaly

Nyasatu G Chamba et al. Endocrinol Diabetes Metab Case Rep. .

Abstract

Summary: Acromegaly is a rare disease caused by hypersecretion of the growth hormone (GH). Most cases are caused by either pituitary microadenoma or macroadenoma. The GH producing tumors present with clinical manifestations of acromegaly due to excessive GH secretion or symptoms resulting from mass effects of the enlarging tumor. The physical changes are usually slow and, therefore, recognition of the disease is delayed. These adenomas are never malignant but can have significant morbidity and mortality. A subgroup of patients with acromegaly present with severe hyperglycemia resulting in diabetic ketoacidosis (DKA) which requires insulin. Rarely are pituitary tumors responsible for generalized convulsions except when they are too large. We hereby present two cases, the first is that of a 26-year-old female who presented with new onset status epilepticus, DKA with a 1-year history of diabetes mellitus (DM). On examination, she had clinical features of acromegaly. The second case is that of a 34-year-old female who presented with new onset status epilepticus, hyperglycemia with a history of recently diagnosed DM, and features of gigantism. In both cases, their diagnosis was confirmed by elevated serum GH and later by elevated insulin-like growth factor type 1 levels, and CT of the head demonstrating large pituitary macroadenoma. The importance of clinical history and examination, as well as investigations is vital in the recognition of acromegaly. The prognosis of acromegalic patients depends on early clinical recognition and tumor size reduction by either medical or surgical therapy.

Learning points: Conditions such as status epilepticus and DKA may be clinical presentations in patients presenting with acromegaly. Seizures are rare in people with pituitary adenoma and typically occur when the tumor invades the suprasellar area due to mass effect on the brain. This article shows how best we were able to manage the acromegaly complications in a low resource setting. Hyperprolactinemia in acromegaly may be due to disruption of the normal dopaminergic inhibition of prolactin secretion due to mass effect of the macroadenoma, and around 25% of GH-secreting adenomas co-secrete prolactin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Image A and image B show huge spade-like hands. Image C shows macroglossia with teeth ridges on the sides and bitten tongue due to the seizures. Image D shows large feet. Image E shows prominent supraorbital ridges and thick lips.
Figure 2
Figure 2
Fundoscopic examination shows optic nerve atrophy.
Figure 3
Figure 3
Axial CT brain view shows sella mass (left blue arrow). Coronal CT brain view shows sella mass (middle blue arrow). Sagittal CT brain view shows sella mass (right blue arrow).
Figure 4
Figure 4
Axial CT brain view shows sella mass (left blue arrow). Coronal CT brain view shows sella mass (middle blue arrow). Sagittal CT brain view shows sella mass (right blue arrow).

Similar articles

Cited by

References

    1. Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA.Endocrine Society. Acromegaly: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2014. 99 3933–3951. (10.1210/jc.2014-2700) - DOI - PubMed
    1. Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, Renoult PP, Houchard A, Elaraki F, Chanson P.Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study. Endocrine 2019. 63 120–129. (10.1007/s12020-018-1764-4) - DOI - PMC - PubMed
    1. Hannon AM, Thompson CJ, Sherlock M.Diabetes in patients with acromegaly. Current Diabetes Reports 2017. 17 8. (10.1007/s11892-017-0838-7) - DOI - PubMed
    1. Møller N, Schmitz O, Jøorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J.Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. Journal of Clinical Endocrinology and Metabolism 1992. 74 1012–1019. (10.1210/jcem.74.5.1569148) - DOI - PubMed
    1. Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C, Borson-Chazot F, Brue T, Delemer B.French Acromegaly Registry. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. European Journal of Endocrinology 2011. 164 877–884. (10.1530/EJE-10-1050) - DOI - PubMed

LinkOut - more resources